UPDATE 2-Regeneron?s Eylea combination therapy fails mid-stage study
 

UPDATE 2-Regeneron?s Eylea combination therapy fails mid-stage study
Sept 30 (Reuters) - Regeneron Pharmaceuticals Inc said a combination therapy containing its flagship eye drug,Eylea, was inferior to Eylea alone in a mid-stage trialinvolving patients with wet...http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...F4:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...F4:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/8Q5_zduWJUU